- Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong. A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective. Clin Mol Hepatol 2022;28:91
- Maria Lúcia Gomes Ferraz, Leonora de Zorzi Piccoli, Rosamar Rezende, Luiz Augusto Borba, Alcindo Pissaia Junior, Hugo Cheinquer, Giovanni Faria Silva, Paulo Roberto Abrão Ferreira, Cristiane Alves Villela-Nogueira, Daniel Ferraz Mazo, Fernanda Fernandes Souza, Liana Codes, Claudia Alexandra Pontes Ivantes, Geisa Perez Medina Gomide, Gustavo Henrique Santos Pereira, Mário Guimarães Pessôa, Alex Vianey Callado França, Arlene dos Santos Pinto, Rosângela Teixeira, Paulo Lisboa Bittencourt. National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents. The Brazilian Journal of Infectious Diseases 2022;26:102388
- . Sofosbuvir. Reactions Weekly 2021;1837:646
- Carlo Smirne, Antonio D'Avolio, Mattia Bellan, Alessandro Gualerzi, Maria G. Crobu, Mario Pirisi. Sofosbuvir‐based therapies in genotype 2 hepatitis C virus cirrhosis: A real‐life experience with focus on ribavirin dose. Pharmacol Res Perspect 2021;9
